Show simple item record

dc.contributor.authorSillence, KAen
dc.contributor.authorRoberts, LAen
dc.contributor.authorHollands, HJen
dc.contributor.authorThompson, HPen
dc.contributor.authorKiernan, Men
dc.contributor.authorMadgett, TEen
dc.contributor.authorWelch, CRen
dc.contributor.authorAvent, NDen
dc.date.accessioned2015-11-11T17:58:28Z
dc.date.available2015-11-11T17:58:28Z
dc.date.issued2015-11en
dc.identifier.urihttp://hdl.handle.net/10026.1/3798
dc.description.abstract

BACKGROUND: Noninvasive genotyping of fetal RHD (Rh blood group, D antigen) can prevent the unnecessary administration of prophylactic anti-D to women carrying RHD-negative fetuses. We evaluated laboratory methods for such genotyping. METHODS: Blood samples were collected in EDTA tubes and Streck® Cell-Free DNA™ blood collection tubes (Streck BCTs) from RHD-negative women (n = 46). Using Y-specific and RHD-specific targets, we investigated variation in the cell-free fetal DNA (cffDNA) fraction and determined the sensitivity achieved for optimal and suboptimal samples with a novel Droplet Digital™ PCR (ddPCR) platform compared with real-time quantitative PCR (qPCR). RESULTS: The cffDNA fraction was significantly larger for samples collected in Streck BCTs compared with samples collected in EDTA tubes (P < 0.001). In samples expressing optimal cffDNA fractions (≥4%), both qPCR and digital PCR (dPCR) showed 100% sensitivity for the TSPY1 (testis-specific protein, Y-linked 1) and RHD7 (RHD exon 7) assays. Although dPCR also had 100% sensitivity for RHD5 (RHD exon 5), qPCR had reduced sensitivity (83%) for this target. For samples expressing suboptimal cffDNA fractions (<2%), dPCR achieved 100% sensitivity for all assays, whereas qPCR achieved 100% sensitivity only for the TSPY1 (multicopy target) assay. CONCLUSIONS: qPCR was not found to be an effective tool for RHD genotyping in suboptimal samples (<2% cffDNA). However, when testing the same suboptimal samples on the same day by dPCR, 100% sensitivity was achieved for both fetal sex determination and RHD genotyping. Use of dPCR for identification of fetal specific markers can reduce the occurrence of false-negative and inconclusive results, particularly when samples express high levels of background maternal cell-free DNA.

en
dc.format.extent1399 - 1407en
dc.languageengen
dc.language.isoengen
dc.subjectBlood Specimen Collectionen
dc.subjectDNAen
dc.subjectFemaleen
dc.subjectGenotypeen
dc.subjectGenotyping Techniquesen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectPolymerase Chain Reactionen
dc.subjectPregnancyen
dc.subjectReal-Time Polymerase Chain Reactionen
dc.subjectRh-Hr Blood-Group Systemen
dc.subjectSensitivity and Specificityen
dc.subjectSex Determination Analysisen
dc.titleFetal Sex and RHD Genotyping with Digital PCR Demonstrates Greater Sensitivity than Real-time PCR.en
dc.typeJournal Article
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/26354802en
plymouth.issue11en
plymouth.volume61en
plymouth.publication-statusPublisheden
plymouth.journalClin Chemen
dc.identifier.doi10.1373/clinchem.2015.239137en
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/00 All current users
plymouth.organisational-group/Plymouth/00 All current users/Academics
plymouth.organisational-group/Plymouth/00 All current users/Academics/Plymouth University Peninsula School of Medicine and Dentistry
plymouth.organisational-group/Plymouth/00 All current users/Academics/Plymouth University Peninsula School of Medicine and Dentistry/School of Biomedical & Healthcare Sciences
plymouth.organisational-group/Plymouth/00 All current users/Professional Services
plymouth.organisational-group/Plymouth/Plymouth University Peninsula Schools of Medicine and Dentistry
plymouth.organisational-group/Plymouth/Plymouth University Peninsula Schools of Medicine and Dentistry/Biomedical Research Group
plymouth.organisational-group/Plymouth/Plymouth University Peninsula Schools of Medicine and Dentistry/Biomedical Research Group/RC Reporting Group BRG
plymouth.organisational-group/Plymouth/Plymouth University Peninsula Schools of Medicine and Dentistry/School of Biomedical & Healthcare Sciences
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dc.publisher.placeUnited Statesen
dcterms.dateAccepted2015-08-24en
dc.identifier.eissn1530-8561en
rioxxterms.versionofrecord10.1373/clinchem.2015.239137en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2015-11en
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
File version is made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or file.
PEARL is managed by Technology and Information Services.
Theme by 
@mire NV